Burt, A. L., L’Italien, G., Perlman, S. L., Rosenthal, L. S., Kuo, S., Ashizawa, T., Zesiewicz, T., Dietiker, C., Opal, P., Duquette, A., Wilmot, G. R., Shakkottai, V. G., Gomez, C. M., Srinivasan, S. R., Paulson, H., Geschwind, M. D., Worley, S., Onyike, C. U., Billnitzer, A., … Schmahmann, J. D. (2025). Spinocerebellar Ataxia Progression Measured with the Patient‐Reported Outcome Measure of Ataxia. Movement Disorders. Portico. https://doi.org/10.1002/mds.30158

Rossi, M., Schaake, S., Usnich, T., Boehm, J., Steffen, N., Schell, N., Krüger, C., Gül‐Demirkale, T., Bahr, N., Kleinz, T., Madoev, H., Laabs, B., Gan‐Or, Z., Alcalay, R. N., Lohmann, K., & Klein, C. (2025). Classification and Genotype–Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review. Movement Disorders. Portico. https://doi.org/10.1002/mds.30141

Zhao, Y., Lai, Y., Darweesh, S. K. L., Bloem, B. R., Forsgren, L., Hansen, J., Katzke, V. A., Masala, G., Sieri, S., Sacerdote, C., Panico, S., Zamora‐Ros, R., Sánchez, M., Huerta, J. M., Guevara, M., Vinagre‐Aragon, A., Vineis, P., Lill, C. M., Miller, G. W., … Vermeulen, R. (2024). Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome‐Wide Association Study. Movement Disorders. Portico. https://doi.org/10.1002/mds.30054

Vieira, S. R. L., Mezabrovschi, R., Toffoli, M., Del Pozo, S. L., Menozzi, E., Mullin, S., Yalkic, S., Limbachiya, N., Koletsi, S., Loefflad, N., Lopez, G. J., Gan‐Or, Z., Alcalay, R. N., Sidransky, E., & Schapira, A. H. V. (2024). Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson’s Disease. Movement Disorders. Portico. https://doi.org/10.1002/mds.30006

Shiner, T., Kavé, G., Mirelman, A., Regev, K., Piura, Y., Goldstein, O., Gana Weisz, M., Bar‐Shira, A., Gurevich, T., Orr‐Urtreger, A., Alcalay, R. N., Giladi, N., & Bregman, N. (2024). Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies. Movement Disorders. Portico. https://doi.org/10.1002/mds.30003

De Giorgis, V., Bhatia, K. P., Boespflug‐Tanguy, O., Gras, D., Marina, A. D., Desurkar, A., Toledo, M., Miller, I., Rotstein, M., Schneider, S. A., Tarquinio, D. C., Weber, Y., Brandabur, M., Mayhew, J., Koutsoukos, T., & De Vivo, D. C. (2024). Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study. Movement Disorders, 39(8), 1386–1396. Portico. https://doi.org/10.1002/mds.29822

LoPiccolo, M. K., Wang, Z., Eshed, G. M., Fierro, L., Stauffer, C., Wang, K., Zhang, J., Tatsuoka, C., Balwani, M., Zou, W., & Alcalay, R. N. (2024). Skin α‐Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease. Movement Disorders. Portico. https://doi.org/10.1002/mds.29935

Goldman, J. S., Uhlmann, W. R., Naini, A. B., Klitzman, R. L., & Marder, K. S. (2023). Genetic Testing of HTT Modifiers for Huntington’s Disease: Considerations for Clinical Guidelines. Movement Disorders, 38(12), 2151–2154. Portico. https://doi.org/10.1002/mds.29650

Senkevich, K., Beletskaia, M., Dworkind, A., Yu, E., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Fahn, S., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Greenbaum, L., Hassin‐Baer, S., Nagornov, I., Tyurin, A., Miliukhina, I., Timofeeva, A., … Gan‐Or, Z. (2023). Association of Rare Variants in ARSA with Parkinson’s Disease. Movement Disorders, 38(10), 1806–1812. Portico. https://doi.org/10.1002/mds.29521

Pal, G., Cook, L., Schulze, J., Verbrugge, J., Alcalay, R. N., Merello, M., Sue, C. M., Bardien, S., Bonifati, V., Chung, S. J., Foroud, T., Gatto, E., Hall, A., Hattori, N., Lynch, T., Marder, K., Mascalzoni, D., Novaković, I., Thaler, A., … Klein, C. (2023). Genetic Testing in Parkinson’s Disease. Movement Disorders, 38(8), 1384–1396. Portico. https://doi.org/10.1002/mds.29500

Saunders‐Pullman, R., Raymond, D., Ortega, R. A., Shalash, A., Gatto, E., Salari, M., Markgraf, M., Alcalay, R. N., Mascalzoni, D., Mencacci, N. E., Bonifati, V., Merello, M., Chung, S. J., Novakovic, I., Bardien, S., Pal, G., Hall, A., Hattori, N., Lynch, T., … Simuni, T. (2023). International Genetic Testing and Counseling Practices for Parkinson’s Disease. Movement Disorders, 38(8), 1527–1535. Portico. https://doi.org/10.1002/mds.29442

Agin‐Liebes, J., Hickman, R. A., Vonsattel, J. P., Faust, P. L., Flowers, X., Utkina Sosunova, I., Ntiri, J., Mayeux, R., Surface, M., Marder, K., Fahn, S., Przedborski, S., & Alcalay, R. N. (2023). Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders, 38(8), 1541–1545. Portico. https://doi.org/10.1002/mds.29449

Miltenberger‐Miltenyi, G., Jones, A., Tetlow, A. M., Conceição, V. A., Crary, J. F., Ditzel, R. M., Farrell, K., Nandakumar, R., Barton, B., Karp, B. I., Kirby, A., Lett, D. J., Mente, K., Morgello, S., Simon, D. K., & Walker, R. H. (2023). Sphingolipid and Phospholipid Levels Are Altered in Human Brain in Chorea‐Acanthocytosis. Movement Disorders, 38(8), 1535–1541. Portico. https://doi.org/10.1002/mds.29445

Outeiro, T. F., Alcalay, R. N., Antonini, A., Attems, J., Bonifati, V., Cardoso, F., Chesselet, M., Hardy, J., Madeo, G., McKeith, I., Mollenhauer, B., Moore, D. J., Rascol, O., Schlossmacher, M. G., Soreq, H., Stefanis, L., & Ferreira, J. J. (2023). Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson’s Disease.” Movement Disorders, 38(7), 1127–1142. Portico. https://doi.org/10.1002/mds.29419

Blauwendraat, C., Tayebi, N., Woo, E. G., Lopez, G., Fierro, L., Toffoli, M., Limbachiya, N., Hughes, D., Pitz, V., Patel, D., Vitale, D., Koretsky, M. J., Hernandez, D., Real, R., Alcalay, R. N., Nalls, M. A., Morris, H. R., Schapira, A. H. V., Balwani, M., & Sidransky, E. (2023). Polygenic Parkinson’s Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease. Movement Disorders, 38(5), 899–903. Portico. https://doi.org/10.1002/mds.29342

Vollstedt, E., Schaake, S., Lohmann, K., Padmanabhan, S., Brice, A., Lesage, S., Tesson, C., Vidailhet, M., Wurster, I., Hentati, F., Mirelman, A., Giladi, N., Marder, K., Waters, C., Fahn, S., Kasten, M., Brüggemann, N., Borsche, M., … Foroud, T. (2023). Embracing Monogenic Parkinson’s Disease: The MJFF Global Genetic PD Cohort. Movement Disorders, 38(2), 286–303. Portico. https://doi.org/10.1002/mds.29288

Troche, M. S., Curtis, J. A., Sevitz, J. S., Dakin, A. E., Perry, S. E., Borders, J. C., Grande, A. A., Mou, Y., Vanegas‐Arroyave, N., & Hegland, K. W. (2022). Rehabilitating Cough Dysfunction in Parkinson’s Disease: A Randomized Controlled Trial. Movement Disorders, 38(2), 201–211. Portico. https://doi.org/10.1002/mds.29268

Hopfner, F., Tietz, A. K., Ruf, V. C., Ross, O. A., Koga, S., Dickson, D., Aguzzi, A., Attems, J., Beach, T., Beller, A., Cheshire, W. P., van Deerlin, V., Desplats, P., Deuschl, G., Duyckaerts, C., Ellinghaus, D., Evsyukov, V., Flanagan, M. E., Franke, A., … Höglinger, G. (2022). Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy. Movement Disorders, 37(10), 2110–2121. Portico. https://doi.org/10.1002/mds.29164

Fritz, N. E., Busse, M., Muratori, L. M., Rao, A. K., Kloos, A., Kegelmeyer, D., & Quinn, L. (2022). An MDS Evidence‐Based Review on Treatments for Huntington’s Disease. Movement Disorders, 37(7), 1566–1567. Portico. https://doi.org/10.1002/mds.29059

Xu, Y., Feeney, M. P., Surface, M., Novak, D., Troche, M. S., Beck, J. C., & Alcalay, R. N. (2022). Attitudes Toward Telehealth Services Among People Living With Parkinson’s Disease: A Survey Study. Movement Disorders, 37(6), 1289–1294. Portico. https://doi.org/10.1002/mds.28990

Lewis, S. J. G., Factor, S. A., Giladi, N., Hallett, M., Nieuwboer, A., Nutt, J. G., Przedborski, S., & Papa, S. M. (2021). Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson’s Disease. Movement Disorders, 37(2), 264–267. Portico. https://doi.org/10.1002/mds.28837

Bohnen, N. I., Costa, R. M., Dauer, W. T., Factor, S. A., Giladi, N., Hallett, M., Lewis, S. J. G., Nieuwboer, A., Nutt, J. G., Takakusaki, K., Kang, U. J., Przedborski, S., & Papa, S. M. (2021). Discussion of Research Priorities for Gait Disorders in Parkinson’s Disease. Movement Disorders, 37(2), 253–263. Portico. https://doi.org/10.1002/mds.28883

Surface, M., Balwani, M., Waters, C., Haimovich, A., Gan‐Or, Z., Marder, K. S., Hsieh, T., Song, L., Padmanabhan, S., Hsieh, F., Merchant, K. M., & Alcalay, R. N. (2021). Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson’s Disease. Movement Disorders, 37(2), 416–421. Portico. https://doi.org/10.1002/mds.28846

Jucaite, A., Cselényi, Z., Kreisl, W. C., Rabiner, E. A., Varrone, A., Carson, R. E., Rinne, J. O., Savage, A., Schou, M., Johnström, P., Svenningsson, P., Rascol, O., Meissner, W. G., Barone, P., Seppi, K., Kaufmann, H., Wenning, G. K., Poewe, W., & Farde, L. (2021). Glia Imaging Differentiates Multiple System Atrophy from Parkinson’s Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis. Movement Disorders, 37(1), 119–129. Portico. https://doi.org/10.1002/mds.28814

Charisis, S., Ntanasi, E., Stamelou, M., Xiromerisiou, G., Maraki, M., Veskoukis, A. S., Yannakoulia, M., Kosmidis, M. H., Anastasiou, C. A., Giagkou, N., Dardiotis, E., Hadjigeorgiou, G., Sakka, P., Kouretas, D., Stefanis, L., & Scarmeas, N. (2021). Plasma Glutathione and Prodromal Parkinson’s Disease Probability. Movement Disorders, 37(1), 200–205. Portico. https://doi.org/10.1002/mds.28826

McDonnell, E. I., Wang, Y., Goldman, J., & Marder, K. (2021). Age of Onset of Huntington’s Disease in Carriers of Reduced Penetrance Alleles. Movement Disorders, 36(12), 2958–2961. Portico. https://doi.org/10.1002/mds.28789